Delivery Order SPE2DB22D3010-SPE2DB25FP3FM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,254.40 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/ml SureClick auto-injectors. The contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed price delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters and serves as a...
- The Defense Logistics Agency awarded a $4,761.52 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick, a PCSK9 inhibitor used in cardiovascular disease management. This contract, awarded on July 18, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order was competitively awarded with no set-aside...
- The Defense Logistics Agency has awarded a delivery order valued at $4,865.38 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,061.18 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick medication, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement fulfilling federal pharmaceutical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the...
- The Defense Logistics Agency awarded a delivery order valued at $2,524.72 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick, a pharmaceutical product used in cardiovascular disease management. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, under a firm fixed-price arrangement with no set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $1,316.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of REPATHA 140 MG/ML SURECLICKML. This order was placed under an existing Prime Vendor contract vehicle to provide pharmaceutical products and services to DOD medical treatment facilities. Amerisourcebergen will deliver the specified medication to a location in Conshohocken, Pennsylvania by September 26, 2023 to support DLA's mission of providing the military with...
- The Defense Logistics Agency awarded a $4,165.68 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for Repatha 140 mg/ml SureClick auto-injectors. The contract represents a firm fixed price delivery under a non-competitive set-aside arrangement and is scheduled for completion by July 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and holds a substantial $999.999 billion...
- The Defense Logistics Agency awarded a $3,007.73 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,351.83 firm fixed-price contract is for the delivery of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product. The contract has an ultimate completion date of June 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- On July 22, 2025, the Defense Logistics Agency awarded a delivery order contract valued at $1,041.42 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitive, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by July 23, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3FMDelivery Order
The Defense Logistics Agency awarded a $4,247.74 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick medication on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products, medical supplies, specialty medications, vaccines, and other healthcare commodities across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems worldwide. This delivery order represents a routine transaction under that larger contract vehicle, fulfilling specific medication requirements for the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/18/25 |